Novo Nordisk
NVO
#19
Rank
HK$3.721 T
Marketcap
HK$819.75
Share price
-1.49%
Change (1 day)
5.87%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of September 2024 : HK$463.40 Billion

According to Novo Nordisk's latest financial reports the company's total assets are HK$463.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$363.76 B34.01%
2022-12-31HK$271.45 B17.56%
2021-12-31HK$230.91 B24.34%
2020-12-31HK$185.70 B26.61%
2019-12-31HK$146.67 B10.37%
2018-12-31HK$132.89 B3.09%
2017-12-31HK$128.92 B20.38%
2016-12-31HK$107.09 B2.71%
2015-12-31HK$104.26 B6.8%
2014-12-31HK$97.62 B-3.32%
2013-12-31HK$100.98 B11.88%
2012-12-31HK$90.25 B3.1%
2011-12-31HK$87.54 B2.65%
2010-12-31HK$85.27 B4.3%
2009-12-31HK$81.76 B11.08%
2008-12-31HK$73.60 B0.93%
2007-12-31HK$72.93 B18.32%
2006-12-31HK$61.63 B19.84%
2005-12-31HK$51.43 B-3.55%
2004-12-31HK$53.32 B17.95%
2003-12-31HK$45.21 B28.2%
2002-12-31HK$35.26 B9.11%
2001-12-31HK$32.32 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$1.708 T 268.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$588.47 B 26.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$729.07 B 57.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.082 T 133.62%๐Ÿ‡ซ๐Ÿ‡ท France